[Adams, M. D., Chan, E. R., Molyneaux, N. D., Bonomo, R. A. (2010). Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.,54 (9), 3569–3577.10.1128/AAC.00057-10293497120530228]Search in Google Scholar
[Anonymous (2016a). Carbapenem-resistant Acinetobacter baumannii in healthcare settings. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-carbapenem-resistant-acinetobacter-baumannii-healthcare (accessed 12.04.2021).]Search in Google Scholar
[Anonymous (2016b). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – protocol version 5.3. European Centre for Disease Prevention and Control, Stockholm. https://www.ecdc.europa.eu/en/publications-data/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use-3 (accessed 12.04.2021).]Search in Google Scholar
[Anonymous (2016c). Surveillance Atlas of Infectious Diseases — Antimicrobial resistance. https://ecdc.europa.eu/en/antimicrobial-resistance/surveil-lance-and-disease-data/data-ecdc (accessed 12.04.2021).]Search in Google Scholar
[Anonymous (2017). WHO publishes list of bacteria for which new antibiotics are urgently needed.http://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (accessed 12 April 2021).]Search in Google Scholar
[Bouvet, P. J., Grimont, P. A. (1986). Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov. Acinetobacter haemolyticus sp. nov. Acinetobacter johnsonii sp. nov. and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwofii. Int. J. Syst. Bacteriol.,36 (2), 228–240.10.1099/00207713-36-2-228]Search in Google Scholar
[Brossard, K. A., Campagnari, A. A. (2012). The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun.,80 (1), 228–233.10.1128/IAI.05913-11325568422083703]Search in Google Scholar
[Chen, L., Zheng, D., Liu, B., Yang, J., Jin, Q. (2016). VFDB 2016: Hierarchical and refined dataset for big data analysis —10 years on. Nucl. Acids Res.,44, D694–D697.10.1093/nar/gkv1239470287726578559]Search in Google Scholar
[Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., Brisse, S. (2010). The population structure of Acinetobacter baumannii: Expanding multi-resistant clones from an ancestral susceptible genetic pool. PLoS One., 5 (4), e10034.10.1371/journal.pone.0010034285092120383326]Search in Google Scholar
[Perez, F. Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.,51 (10) 3471–3484.10.1128/AAC.01464-06204329217646423]Search in Google Scholar
[Fishbain, J., Peleg, A. Y. (2010). Treatment of Acinetobacter infections. Clin. Infect. Dis.,51 (1), 79–84.10.1086/65312020504234]Search in Google Scholar
[Fitzpatrick, M. A., Ozer, E. A, Hauser, A. R. (2016). Utility of whole genome sequencing in characterizing Acinetobacter epidemiology and analyzing hospital outbreaks. J. Clin. Microbiol.,54, 593–612.10.1128/JCM.01818-15476797226699703]Search in Google Scholar
[Fournier, P. E., Richet, H. (2006). The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis.,42 (5), 692–699.10.1086/50020216447117]Search in Google Scholar
[Gramatniece, A., Silamikelis, I., Zahare, I., Urtans, V., Zahare, I., Dimina, E., Saule, M., Balode, M., Radovica-Spalvina, I., Klovins, J., Fridmanis, D., Dumpis, U. (2019). Control of Acinetobacter baumannii outbreak in the neonatal intensive care unit in Latvia: Whole-genome sequencing powered investigation and closure of the ward. Antimicrob. Resist. Infect. Control,8, 84.10.1186/s13756-019-0537-z653225631143444]Search in Google Scholar
[Higgins, P. G., Prior, K., Harmsen, D., Seifert, H. (2017). Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS ONE., 12, e0179228.10.1371/journal.pone.0179228546462628594944]Search in Google Scholar
[Jünemann, S., Sedlazeck, F. J., Prior, K., Albersmeier, A., John, U., Kalinowski, J., Mellmann, A., Goesmann, A., Haeseler, A. von, Stoye, J., Harmsen, D. (2013). Updating benchtop sequencing performance comparison. Nat. Biotechnol.,31 (4), 294–296.10.1038/nbt.252223563421]Search in Google Scholar
[Kanafani, Z. A., Souha, S. K. (2021). Acinetobacter infection: Epidemiology, microbiology, pathogenesis, clinical features, and diagnosis. https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis (accessed 12.04.2021).]Search in Google Scholar
[Kim, S. J., Kim, Y.-J., Ko, K. S., (2018). Genomic analysis of consecutive Acinetobacterbumanii strains from a single patient. Front Microbiol., 9, 2840.10.3389/fmicb.2018.02840627777530542330]Search in Google Scholar
[Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae I. K., Kim, Y. B, Cha, C. J. C., Jeong, B. C., Lee, S. H. (2017). Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front. Cell. Infect. Microbiol.,7, 55.10.3389/fcimb.2017.00055534658828348979]Search in Google Scholar
[Liepiņš, M., Sīmanis, R., Lejnieks, A. (2016). Decreasing prevalence of multidrug-resistant Acinetobacter Baumannii in Rīga East University Hospital. Proc. Latvian Acad. Sci.,70 (4), 232–236.10.1515/prolas-2016-0037]Search in Google Scholar
[Maragakis, L. L., Perl, T. M. (2008). Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis.,46 (8), 1254–1263.10.1086/52919818444865]Search in Google Scholar
[Mazumder, S. A. (2021). Acinetobacter.https://emedicine.medscape.com/article/236891-overview (accessed 8 March 2021).]Search in Google Scholar
[O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance.https://www.biomerieuxconnection.com/wp-content/uploads/2018/04/Tackling-Drug-Resistant-Infections-Globally_-Final-Report-and-Recommendations.pdf (accessed 12.04.2021).]Search in Google Scholar
[Owens, R. C., Jr., Rice, L. (2006). Hospital-based strategies for combating resistance. Clin. Infect. Dis., 42 (Suppl. 4), S173–S181.10.1086/50066416544268]Search in Google Scholar
[Park, S. Y., Choo, J. Y., Kwon, S. H, Yu, S. N., Lee, E. J., Kim, T. H., Choo, E. J., Jeon, M. H. (2013). Risk factors for mortality in patients with Acinetobacter baumannii bacteremia. Inf. Chemother.,45 (3), 325–330.10.3947/ic.2013.45.3.325384851124396634]Search in Google Scholar
[Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J. Infect. Dis.,197 (8), 1079–1081.10.1086/53345218419525]Search in Google Scholar
[Sefid, F., Rasooli, I., Jahangiri, A., Bazmara, H. (2015). Functional exposed amino acids of BauA as potential immunogen against Acinetobacter baumannii. Acta Biotheor.,63 (2),129–149.10.1007/s10441-015-9251-225840681]Search in Google Scholar
[Xiao, D., Wang, L., Zhang, D., Xiang, D., Liu, Q., Xing, X. (2017). Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis. Exper. Ther. Med.,13 (4), 1630–1633.10.3892/etm.2017.4137537756928413520]Search in Google Scholar
[Zerbino, D.R., Birney, E. (2008). Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res., 18 (5), 821–829.10.1101/gr.074492.107233680118349386]Search in Google Scholar